Anlotinib Not Yet Recruiting Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03897283Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors